Insights After 40 Years of the Fontan Operation

World Journal for Pediatric and Congenital Heart Surgery

Volumn 1, Issue 3, 2010, Pages 328-343

  Chin, Alvin J ^a,b   Whitehead, Kevin K ^a,b   Watrous, Raymond L ^c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

biomarkers; cardiac index; endothelium; Fontan; hypoplastic left heart; Islet 1; single ventricle; Tbx5

Indexed keywords

EID: 84990318265     PISSN: 21501351     EISSN: 21500136     Source Type: Journal    
DOI: 10.1177/2150135110379623     Document Type: Review

References (83)

1. Fontan F Baudet E. Surgical repair of tricuspid atresia. Thorax. 1971; 26: 240–248.
2. de Leval MR. Evolution of the Fontan-Kreutzer procedure. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu. 2010; 13(1):91–95.
3. Kreutzer GO Schlichter AJ Kreutzer C. The Fontan/Kreutzer procedure at 40: an operation for the correction of tricuspid atresia. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu. 2010; 13: 84–90.
4. Khairy P Fernandes SM Mayer JE Jr, et al. Long-term survival, modes of death, and predictors of mortality in patients with Fontan surgery. Circulation. 2008; 117: 85–92.
5. Marino BS Shera D Wernovsky G, et al. The development of the pediatric cardiac quality of life inventory: a quality of life measure for children and adolescents with heart disease. Qual Life Res. 2008; 17: 613–626.
6. Feldt RH Driscoll DJ Offord KP, et al. Protein-losing enteropathy after the Fontan operation. J Thorac Cardiovasc Surg. 1996; 112: 672–680.
7. Ryerson L Goldberg C Rosenthal A Armstrong A. Usefulness of heparin therapy in protein-losing enteropathy associated with single ventricle palliation. Am J Cardiol. 2008; 101: 248–251.
8. Jacobs ML Schneider DJ Pourmaghadam KK Pizarro C Norwood WI. Total cavopulmonary connection to one lung. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu. 2004; 7: 72–79.
9. Mertens L Hagler DJ Sauer U Somerville J Gewillig M. Protein-losing enteropathy after the Fontan operation: an international multicenter study. J Thorac Cardiovasc Surg. 1998; 115: 1063–1073.
10. Triedman JK Bridges ND Mayer JE Jr Lock JE. Prevalence and risk factors for aortopulmonary collateral vessels after Fontan and bidirectional Glenn procedures. J Am Coll Cardiol. 1993; 22: 207–215.
11. Fogel MA Donofrio MT Ramaciotti C Hubbard AM Weinberg PM. Magnetic resonance and echocardiographic imaging of pulmonary artery size throughout stages of Fontan reconstruction. Circulation. 1994; 90: 2927–2936.
12. Grosse-Wortmann L Al-Otay A Yoo SJ. Aortopulmonary collaterals after bidirectional cavopulmonary connection or Fontan completion: quantification with MRI. Circ Cardiovasc Imaging. 2009; 2: 219–225.
13. Whitehead KK Gillespie MJ Harris MA Fogel MA Rome JJ. Noninvasive quantification of systemic-to-pulmonary collateral flow: a major source of inefficiency in patients with superior cavopulmonary connections. Circ Cardiovasc Imaging. 2009; 2: 405–411.
14. Cohen MI Bush DM Ferry RJ Jr, et al. Somatic growth failure after the Fontan operation. Cardiol Young. 2000; 10: 447–457.
15. Witzel C Sreeram N Coburger S Schickendantz S Brockmeier K Schoenau E. Outcome of muscle and bone development in congenital heart disease. Eur J Pediatr. 2006; 165: 168–174.
16. Colloridi V Roggini M Formigari R Ventriglia F Giglion E. Plastic bronchitis as a rare complication of Fontan’s operation. Pediatr Cardiol. 1990; 11: 228.
17. Camposilvan S Milanesi O Stellin G Pettenazzo A Zancan L D’Antiga L. Liver and cardiac function in the long term after Fontan operation. Ann Thorac Surg. 2008; 86: 177–182.
18. Shachar GB Fuhrman BP Wang Y Lucas RV Jr Lock JE. Rest and exercise hemodynamics after the Fontan procedure. Circulation. 1982; 65: 1043–1048.
19. Whitehead KK Pekkan K Kitajima HD Paridon SM Yoganathan AP Fogel MA. Nonlinear power loss during exercise in single-ventricle patients after the Fontan: insights from computational fluid dynamics. Circulation. 2007; 116(11 Suppl):I165–I171.
20. Whitehead K Sundareswaran K Parks W Harris M Yoganathan A Fogel M. Blood flow distribution in a large series of patients having the Fontan operation: a cardiac magnetic resonance velocity mapping study. J Thorac Cardiovasc Surg. 2009; 138: 96–102.
21. Rychik J. Forty years of the Fontan operation: a failed strategy. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu. 2010; 13: 96–100.
22. Dodge-Khatami A Kadner A Berger F Dave H Turina MI Prêtre R. In the footsteps of senning: lessons learned from atrial repair of transposition of the great arteries. Ann Thorac Surg. 2005; 79: 1433–1444.
23. Siebenmann R von Segesser L Schneider K Schneider J Senning A Turina M. Late failure of systemic ventricle after atrial correction for transposition of great arteries. Eur J Cardiothorac Surg. 1989; 3: 119–124.
24. Greutmann M Tobler D Grewal J, et al. A reminder from the past: a 49-year-old patient with transposition of the great arteries palliated with Dr. Thomas Baffes’ and Dr. William Mustard’s original operations. J Am Soc Echocardiogr. 2009; 22: 1310.e1–1310.e4.
25. Hörer J Karl E Theodoratou G, et al. Incidence and results of reoperations following the Senning operation: 27 years of follow-up in 314 patients at a single center. Eur J Cardiothorac Surg. 2008; 33: 1061–1067.
26. Hopkins WE Waggoner AD. Severe pulmonary hypertension without right ventricular failure: the unique hearts of patients with Eisenmenger syndrome. Am J Cardiol. 2002; 89: 34–38.
27. Williams IA Sleeper LA Colan SD, et al for the Pediatric Heart Network Investigators. Functional state following the Fontan procedure. Cardiol Young. 2009; 19: 320–330.
28. Hirsch JC Goldberg C Bove EL, et al. Fontan operation in the current era: a 15-year single institution experience. Ann Surg. 2008; 248: 402–410.
29. Jacobs ML Pelletier GJ Pourmoghadam KK, et al. Protocols associated with no mortality in 100 consecutive Fontan procedures. Eur J Cardiothorac Surg. 2008; 33: 626–632.
30. Hosein RBM Clarke AJB McGuirk SP, et al. Factors influencing early and late outcome following the Fontan procedure in the current era: the ‘two commandments’? Eur J Cardiothorac Surg. 2007; 31: 344–353.
31. Brown JW Ruzmetov M Deschner BW Rodefeld MD Turrentine MW. Lateral tunnel Fontan in the current era: is it still a good option? Ann Thorac Surg. 2010; 89: 556–563.
32. Reim I Frasch M. Genetic and genomic dissection of cardiogenesis in the Drosophila model. Pediatr Cardiol. 2010; 31: 325–334.
33. Pereira FA Qiu Y Zhou G Tsai M-J Tsai SY. The orphan nuclear receptor COUP-TFII is required for angiogenesis and heart development. Genes Dev. 1999; 13: 1037–1049.
34. Karlsson O Thor S Norberg T Ohlsson H Edlund T. Insulin gene enhancer binding protein Isl-1 is a member of a novel class of proteins containing both a homeo- and a Cys-His domain. Nature. 1990; 344: 879–882.
35. Cai C-L Liang X Shi Y, et al. Isl1 identifies a cardiac progenitor population that proliferates prior to differentiation and contributes a majority of cells to the heart. Dev Cell. 2003; 5: 877–889.
36. Bu L Jiang X Martin-Puig S, et al. Human ISL1 heart progenitors generate diverse multipotent cardiovascular cell lineages. Nature. 2009; 460: 113–117.
37. Prall OWJ Menon MK Solloway MJ, et al. An Nkx2-5/Bmp2/Smad1 negative feedback loop controls heart progenitor specification and proliferation. Cell. 2007; 128: 947–959.
38. Brade T Gessert S Kühl M Pandur P. The amphibian second heart field: Xenopus islet-1 is required for cardiovascular development. Dev Biol. 2007; 311: 297–310.
39. Tao Y Wang J Tokusumi T Gajewski K Schulz RA. Requirement of the LIM homeodomain transcription factor tailup for normal heart and hematopoietic organ formation in Drosophila melanogaster. Mol Cell Biol. 2007; 27: 3962–3969.
40. University of Washington. Biology 453: Comparative Vertebrate Anatomy. Open access lab notes. Available at: http://courses.washington.edu/chordate/453labs/453lab13-2010.pdf. Accessed June 1, 2010.
41. Van Mierop LHS Kutsche LM. Comparative anatomy of the ventricular septum. In: Wenink ACG, Oppenheimer-Dekker A, Moulaert AJ,eds. The Ventricular Septum of the Heart. Boston, Massachusetts: Martinus Nijhoff Publishers; 1981: 35–46.
42. Bruneau BG Logan M Davis N, et al. Chamber-specific cardiac expression of Tbx5 and heart defects in Holt-Oram syndrome. Dev Biol. 1999; 211: 100–108.
43. Koshiba-Takeuchi K Mori AD Kaynak BL, et al. Reptilian heart development and the molecular basis of cardiac chamber evolution. Nature. 2009; 461: 95–98.
44. Kolditz DP. Cardiac development in relation to clinical supraventricular arrhythmias: focus on structure-function relations [Theses]. Open access publication in the Leiden University Repository. Available at: https://openaccess.leidenuniv.nl/bitstream/1887/13721/7/01.pdf. Accessed June 1, 2010.
45. Bruneau BG Nemer G Schmitt JP, et al. A murine model of Holt-Oram syndrome defines roles of the T-box transcription factor Tbx5 in cardiogenesis and disease. Cell. 2001; 106: 709–721.
46. Mattingly C Parton A Dowell L Rafferty J Barnes D. Cell and molecular biology of marine elasmobranchs: Squalus acanthias and Raja erinacea. Zebrafish. 2004; 1: 111–120.
47. Bradshaw CJA Mollet HF Meekan MG. Inferring population trends for the world’s largest fish from mark-recapture estimates of survival. J Anim Ecol. 2007; 76: 480–489.
48. Lai NC Korsmeyer KE Katz S Holts DB Laughlin LM Graham JB. Hemodynamics and blood properties of the shortfin mako shark, Isurus oxyrinchus. Copeia. 1997; 2: 424–428.
49. Sanchez-Quintana D García-Martínez V Climent V Hurlé JM. Myocardial fiber and connective tissue architecture in the fish heart ventricle. J Exp Zool. 1996; 275: 112–124.
50. Franco D Gallego A Habets PEMH Sans-Coma V Moorman AFM. Species-specific differences of myosin content in the developing cardiac chambers of fish, birds, and mammals. Anat Rec. 2002; 268: 27–37.
51. Nemeh HW Reddy S Walters HL 3rd Hakimi M Ross RD. Restrictive interatrial communication in hypoplastic left heart syndrome after modified Fontan repair. Ann Thorac Surg. 2003; 76: 2089–2091.
52. Uchida T Uemura H Yagihara T Tsukano S Kitamura S. Pulmonary venous obstruction after total cavopulmonary connection in heterotaxy. Ann Thorac Surg. 2002; 73: 273–274.
53. Fogel MA Chin AJ. Imaging of pulmonary venous pathway obstruction in patients after the modified Fontan procedure. J Am Coll Cardiol. 1992; 20: 181–190.
54. Sundareswaran KS de Zélicourt D Sharma S, et al. Correction of pulmonary arteriovenous malformation using image-based surgical planning. J Am Coll Cardiol. 2009; 2: 1024–1030.
55. Newman B Feinstein JA Cohen RA, et al. Congenital extrahepatic portosystemic shunt associated with heterotaxy and polysplenia. Pediatr Radiol. 2010; 40(7):1222–1230.
56. Paridon SM Mitchell PD Colan SD, et al Pediatric Heart Network Investigators. A cross-sectional study of exercise performance during the first 2 decades of life after the Fontan operation. J Am Coll Cardiol. 2008; 52(2):99–107.
57. Luo C Ware DL Zwischenberger JB Clark JW Jr. Using a human cardiopulmonary model to study and predict normal and diseased ventricular mechanics, septal interaction, and atrioventricular blood flow patterns. Cardiovasc Eng. 2007; 7: 17–31.
58. Watrous RL. A computational model of cardiovascular physiology and heart sound generation. Conf Proc IEEE Eng Med Biol Soc. 2009; 2009: 3105–3110.
59. Redington AN. The physiology of the Fontan circulation. Prog Pediatr Cardiol. 2006; 22: 179–186.
60. Mertens L Dumoulin M Gewillig M. Effect of percutaneous fenestration of the atrial septum on protein-losing enteropathy after the Fontan operation. Br Heart J. 1994; 72: 591–592.
61. Warnes CA Feldt RH Hagler DJ. Protein-losing enteropathy after the Fontan operation: successful treatment by percutaneous fenestration of the atrial septum. Mayo Clin Proc. 1996; 71: 378–379.
62. Rychik J Rome JJ Jacobs ML. Late surgical fenestration for complications after the Fontan operation. Circulation. 1997; 96: 33–36.
63. Cohen MI Rhodes LA Wernovsky G Gaynor JW Spray TL Rychik J. Atrial pacing: an alternative treatment for protein-losing enteropathy after the Fontan operation. J Thorac Cardiovasc Surg. 2001; 121: 582–583.
64. Chaudhari M Stumper O. Plastic bronchitis after Fontan operation: treatment with stent fenestration of the Fontan circuit. Heart. 2004; 90: 801.
65. Wilson J Russell J Williams W Benson L. Fenestration of the Fontan circuit as treatment for plastic bronchitis. Pediatr Cardiol. 2005; 26: 717–719.
66. Chin AJ Stephens P Goldmuntz E Leonard MB. Serum alkaline phosphatase reflects post-Fontan hemodynamics in children. Pediatr Cardiol. 2009; 30: 138–145.
67. Franchini M Targher G Lippi G. Serum bilirubin levels and cardiovascular risk: a Janus Bifrons? Adv Clin Chem. 2010; 50: 47–63.
68. Reinhardt Z Uzun O Bhole V, et al. Sildenafil in the management of the failing Fontan circulation. Cardiol Young. 2010 Jun 2 [Epub ahead of print].
69. Opocher F Varnier M Sanders SP, et al. Effects of aerobic exercise training in children after the Fontan operation. Am J Cardiol. 2005; 95: 150–152.
70. Rodefeld MD Coats B Fisher T, et al. Cavopulmonary assist for the univentricular Fontan circulation: von Karman viscous impeller pump. J Thorac Cardiovasc Surg. 2010 Jun 17 [Epub ahead of print].
71. Lacour-Gayet FG Lanning CJ Stoica S, et al. An artificial right ventricle for failing Fontan: in vitro and computational study. Ann Thorac Surg. 2009; 88: 170–176.
72. Akita C Nakamura T. Clinical image: extrahepatic portosystemic venous shunt presenting as galactosaemia. Pediatr Radiol. 2010; 40(7):1300.
73. Benedito R Roca C Sorensen I, et al. The notch ligands Dll4 and Jagged1 have opposing effects on angiogenesis. Cell. 2009; 137: 1124–1135.
74. David L Mallet C Keramidas M, et al. Bone morphogenetic protein-9 is a circulating vascular quiescence factor. Circ Res. 2008; 102: 914–922.
75. Park SO Lee YJ Seki T, et al. ALK5- and TGFBR2-independent role of ALK1 in the pathogenesis of hereditary hemorrhagic telangiectasia type 2. Blood. 2008; 111: 633–642.
76. Brantly M Nukiwa T Crystal RG. Molecular basis of alpha-1-antitrypsin deficiency. Am J Med 1988; 84 Suppl 1: 13–31.
77. Shao MX Nadel JA. Neutrophil elastase induces MUC5AC mucin production in human airway epithelial cells via a cascade involving protein kinase C, reactive oxygen species, and TNF-alpha-converting enzyme. J Immunol. 2005; 175: 4009–16.
78. Kwon BS Bae EJ Kim GB Noh CI Choi JY Yun YS. Development of bilateral diffuse pulmonary arteriovenous fistula after Fontan procedure: is there nonhepatic factor? Ann Thorac Surg. 2009; 88: 677–680.
79. Grattan MJ McCrindle BW. Recurrent exacerbations of protein-losing enteropathy after initiation of growth hormone therapy in a Fontan patient controlled with spironolactone. Congenit Heart Dis. 2010; 5: 165–167.
80. Clapp C Thebault S Jeziorski MC Martínez De La Escalera G. Peptide hormone regulation of angiogenesis. Physiol Rev. 2009; 89: 1177–1215.
81. Banziger-Tobler NE Halin C Kajiya K Detmar M. Growth hormone promotes lymphangiogenesis. Am J Pathol. 2008; 173: 586–597.
82. Odegard KC Zurakowski D DiNardo JA, et al. Prospective longitudinal study of coagulation profiles in children with hypoplastic left heart syndrome from stage I through Fontan completion. J Thorac Cardiovasc Surg. 2009; 137: 934–941.
83. Binotto MA Maeda NY Lopes AA. Altered endothelial function following the Fontan procedure. Cardiol Young. 2008; 18: 70–74.